CY1115914T1 - Δερματολογικες συνθεσεις που περιεχουν συνδυασμο υπεροξυγονουχων λιπιδιων και ψευδαργυρου και οι χρησεις τους ιδιαιτερα στη θεραπεια του ερπητα - Google Patents
Δερματολογικες συνθεσεις που περιεχουν συνδυασμο υπεροξυγονουχων λιπιδιων και ψευδαργυρου και οι χρησεις τους ιδιαιτερα στη θεραπεια του ερπηταInfo
- Publication number
- CY1115914T1 CY1115914T1 CY20141101089T CY141101089T CY1115914T1 CY 1115914 T1 CY1115914 T1 CY 1115914T1 CY 20141101089 T CY20141101089 T CY 20141101089T CY 141101089 T CY141101089 T CY 141101089T CY 1115914 T1 CY1115914 T1 CY 1115914T1
- Authority
- CY
- Cyprus
- Prior art keywords
- composition
- treatment
- hydroxypatic
- compositions containing
- skin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Η εφεύρεση αφορά σε μια δερματολογική σύνθεση η οποία περιέχει σαν δραστικούς παράγοντες ή ουσιώδη συστατικά, ένα συνδυασμό υπεροξυγονούχων λιπιδίων, ειδικότερα που παρουσιάζουν ποσοστό υπεροξυγόνωσης μεταξύ 5 και 600 meq/kg υπεροξυγονούχων λιπιδίων• και ψευδάργυρο σε ανόργανη μορφή ή σε μορφή συμβατή με δερματολογική χρήση, όπου η εν λόγω σύνθεση είναι διατυπωμένη για τοπική εφαρμογή στο δέρμα ή τους βλεννογόνους. Αυτή η σύνθεση μπορεί να χρησιμοποιηθεί, σαν ιατρική διάταξη, για να βοηθήσει στην επούλωση ή και την ανασύσταση επιδερμίδας που έχει υποστεί βλάβη ή και να δράσει σαν αναλγητικός παράγοντας στο δέρμα ή τους βλεννογόνους, ιδιαίτερα στη θεραπεία των συμπτωμάτων του έρπητα, του κνησμού, της φαγούρας, των ερεθισμών, του εκζέματος, των εγκαυμάτων, και ειδικότερα στη θεραπεία του επιχείλιου έρπητα ή του έρπητα γεννητικών οργάνων.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0959604A FR2954701B1 (fr) | 2009-12-24 | 2009-12-24 | Compositions dermatologiques contenant une association de lipides peroxydes et de zinc et leurs utilisations notamment dans le traitement de l'herpes |
| EP10195981.5A EP2343038B1 (fr) | 2009-12-24 | 2010-12-20 | Compositions dermatologiques contenant une association de lipides peroxydés et de zinc et leurs utilisations notamment dans le traitement de l'herpès |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1115914T1 true CY1115914T1 (el) | 2017-01-25 |
Family
ID=42227561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141101089T CY1115914T1 (el) | 2009-12-24 | 2014-12-29 | Δερματολογικες συνθεσεις που περιεχουν συνδυασμο υπεροξυγονουχων λιπιδιων και ψευδαργυρου και οι χρησεις τους ιδιαιτερα στη θεραπεια του ερπητα |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9144612B2 (el) |
| EP (1) | EP2343038B1 (el) |
| AR (1) | AR080633A1 (el) |
| BR (1) | BRPI1010325B1 (el) |
| CY (1) | CY1115914T1 (el) |
| DK (1) | DK2343038T3 (el) |
| ES (1) | ES2531407T3 (el) |
| FR (1) | FR2954701B1 (el) |
| HR (1) | HRP20150027T1 (el) |
| PL (1) | PL2343038T3 (el) |
| PT (1) | PT2343038E (el) |
| RS (1) | RS53787B1 (el) |
| SI (1) | SI2343038T1 (el) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6139506B2 (ja) * | 2011-04-04 | 2017-05-31 | コロプラスト アクティーゼルスカブ | 接着パッチ |
| CA2979938A1 (en) * | 2015-03-18 | 2016-09-22 | Bionoox Suisse Sa | Compositions comprising dihydroquercetin for use in methods for treating herpes |
| EP3308794B1 (en) * | 2015-06-12 | 2022-10-26 | JFE Mineral Company, Ltd. | Therapeutic agent for skin wound or rough skin |
| FR3053252B1 (fr) * | 2016-06-29 | 2020-04-24 | Laboratoires Carilene | Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2461744A1 (fr) * | 1979-07-19 | 1981-02-06 | Desjonqueres Stephane | Perfectionnement a la peroxydation de matieres grasses |
| FR2591109B1 (fr) | 1985-12-06 | 1989-03-31 | Desjonqueres Stephane | Composition medicamenteuse a base d'huile naturelle d'origine vegetale destinee a etre utilisee pour le traitement d'herpes. |
| JPH06698B2 (ja) * | 1985-12-26 | 1994-01-05 | 積水化学工業株式会社 | 外用貼付剤 |
| FR2731615B1 (fr) * | 1995-03-15 | 1997-07-25 | Fabre Pierre Dermo Cosmetique | Compositions ecran-solaire comprenant un melange de particules d'oxyde de titane et/ou de zinc, leur procede de preparation et leur utilisation |
| FR2744017B1 (fr) * | 1996-01-26 | 1998-04-30 | Carilene Lab | Associations de lipides peroxydes et de composes organosiliciques, compositions cosmetiques et dermatologiques les contenant et leurs applications notamment pour le traitement de l'alopecie |
| FR2797586B1 (fr) * | 1999-08-16 | 2001-11-09 | Stephane Desjonqueres | Utilisation de lipides peroxydes comme agents destines a former un film lipidique sur la peau |
| FR2824474B1 (fr) * | 2001-05-11 | 2004-01-02 | Fabre Pierre Dermo Cosmetique | Composition cosmetique a base de sucralfate et de sulfates de cuivre et de zinc |
| US6475526B1 (en) * | 2001-06-05 | 2002-11-05 | Jeffrey B. Smith | Zinc containing compositions for anti-viral use |
| DE10161729A1 (de) * | 2001-12-15 | 2003-06-18 | Mira Ursic | Medizinische bzw. pharmazeutische Salbenzubereitung |
| US6686392B1 (en) * | 2002-10-01 | 2004-02-03 | Elena Avram | Lipidic zinc compounds and use for treatment of prostatic hypertrophy |
| NL1022532C2 (nl) * | 2003-01-30 | 2004-08-03 | Pronovamedical B V | Samenstelling voor de preventieve behandeling van koortsuitslag. |
| CA2514381A1 (en) * | 2005-07-29 | 2007-01-29 | Collins T. Harvey | Improved topical preparation and method for using same to destroy herpes simplex cells |
| ITRM20070582A1 (it) * | 2007-11-08 | 2009-05-09 | Mauro Carratelli | Composizione farmaceutica comprendente olio e colesterolo perossidati e suoi usi in campo medico. |
-
2009
- 2009-12-24 FR FR0959604A patent/FR2954701B1/fr active Active
-
2010
- 2010-12-17 US US12/971,055 patent/US9144612B2/en active Active
- 2010-12-20 PL PL10195981T patent/PL2343038T3/pl unknown
- 2010-12-20 BR BRPI1010325A patent/BRPI1010325B1/pt not_active IP Right Cessation
- 2010-12-20 RS RS20150043A patent/RS53787B1/en unknown
- 2010-12-20 PT PT101959815T patent/PT2343038E/pt unknown
- 2010-12-20 DK DK10195981.5T patent/DK2343038T3/en active
- 2010-12-20 EP EP10195981.5A patent/EP2343038B1/fr active Active
- 2010-12-20 SI SI201030868T patent/SI2343038T1/sl unknown
- 2010-12-20 ES ES10195981T patent/ES2531407T3/es active Active
- 2010-12-22 AR ARP100104870A patent/AR080633A1/es not_active Application Discontinuation
-
2014
- 2014-12-29 CY CY20141101089T patent/CY1115914T1/el unknown
-
2015
- 2015-01-09 HR HRP20150027AT patent/HRP20150027T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI1010325A2 (pt) | 2014-02-25 |
| AR080633A1 (es) | 2012-04-25 |
| RS53787B1 (en) | 2015-06-30 |
| PL2343038T3 (pl) | 2015-04-30 |
| BRPI1010325B1 (pt) | 2019-09-03 |
| EP2343038B1 (fr) | 2014-11-26 |
| FR2954701A1 (fr) | 2011-07-01 |
| EP2343038A1 (fr) | 2011-07-13 |
| PT2343038E (pt) | 2015-02-05 |
| ES2531407T3 (es) | 2015-03-13 |
| SI2343038T1 (sl) | 2015-03-31 |
| US9144612B2 (en) | 2015-09-29 |
| FR2954701B1 (fr) | 2012-02-03 |
| HRP20150027T1 (hr) | 2015-03-13 |
| DK2343038T3 (en) | 2015-01-26 |
| US20110159106A1 (en) | 2011-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015007366A2 (pt) | derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| BR0308429A (pt) | Aroilpiridinonas monocìclicas como agentes antiinflamatórios | |
| AR077199A1 (es) | Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia | |
| GT200500360A (es) | Compuestos organicos | |
| DOP2013000105A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis | |
| AR090349A1 (es) | Terapia de combinacion para trastornos proliferativos, kit y uso | |
| ECSP088974A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| EA200801698A1 (ru) | Лекарственные композиции для применения в вагине | |
| CL2008003096A1 (es) | Compuestos derivados de piperidino-dihidrotienopirimidinas; inhibidores pde4; composicion farmaceutica que los comprende; y uso en el tratamiento de trastornos o enfermedades de las vias respiratorias o gastrointestinales, como tambien enfermedades inflamatorias de las articulaciones u ojos, entre otras. | |
| BR112012030810A2 (pt) | "c-28 amidas de derivados de ácido c-3 betulínico modificados como inibidores de maturação de hiv" | |
| BR112015029401A2 (pt) | derivados pirazolo-pirrolidin-4-ona e seu uso no tratamento de doenças | |
| CY1115914T1 (el) | Δερματολογικες συνθεσεις που περιεχουν συνδυασμο υπεροξυγονουχων λιπιδιων και ψευδαργυρου και οι χρησεις τους ιδιαιτερα στη θεραπεια του ερπητα | |
| CL2012000446A1 (es) | Uso de una formulación vesicular tópica que comprende uno o más fosfolípidos y uno o más tensoactivos en una razón molar de 1:1 a 25:1 de fosfolípidos a tensoactivos, para el tratamiento de trastornos dermatosos inflamatorios. | |
| HN2001000037A (es) | Derivados de eteres de pirazol como agentes antiinflamatorios/analgesicos | |
| UY30986A1 (es) | Derivados fluorinados de deferiprona | |
| CL2017001913A1 (es) | Composición tópica curativa | |
| WO2007143557A3 (en) | Compounds and methods for treating mammalian gastrointestinal parasitic infections | |
| CO6270217A2 (es) | Formulaciones galenicas de alisquireno y valsartan | |
| CO2019010029A2 (es) | Compuestos de tipo imidazo[4,5-c]quinolin-2-ona deuterados y su uso en el tratamiento del cáncer | |
| UY30847A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
| BRPI0509667A (pt) | azaquinazolinas substituìdas com eficácia antiviral | |
| BRPI0607795A2 (pt) | compostos antiinflamatórios | |
| BR112015001859A2 (pt) | tratamento de inflamação utilizando serelaxina | |
| BRPI0715361B8 (pt) | uso de polietileno glicol em inflamação relacionada com doenças ou distúrbios tópicos e cicatrização de ferimento |